ZyVersa Therapeutics to be delisted from Nasdaq, continues trading on OTCQB
NegativeFinancial Markets

ZyVersa Therapeutics is facing a delisting from Nasdaq, which is a significant setback for the company. This move to continue trading on the OTCQB market highlights the challenges the firm is encountering in maintaining its listing on a major exchange. The delisting could impact investor confidence and the company's ability to raise capital, making it a crucial moment for ZyVersa as it navigates its future.
— Curated by the World Pulse Now AI Editorial System